With a price/earnings ratio of 155.7, Cantel Medical Corp P/E ratio is greater than that of about 95.28% of stocks in our set with positive earnings.
With a year-over-year growth in debt of 380.83%, Cantel Medical Corp's debt growth rate surpasses 95.37% of about US stocks.
Cantel Medical Corp's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -40.03%, greater than the shareholder yield of just 10.31% of stocks in our set.
Stocks with similar financial metrics, market capitalization, and price volatility to Cantel Medical Corp are EPC, NVT, CMCO, MTSC, and CSL.
Cantel Medical Corporation provides infection prevention and control products and services in the healthcare market. The company operates in 5 segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis, Specialty Packaging. The company was founded in 1963 and is based in Little Falls, New Jersey.
CMD Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Cantel Medical Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Cantel Medical Corp ranked in the 35th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 39.33%. In terms of the factors that were most noteworthy in this DCF analysis for CMD, they are:
Cantel Medical Corp's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 68.78% of tickers in our DCF set.
Cantel Medical Corp's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
Relative to other stocks in its sector (Healthcare), Cantel Medical Corp has a reliance on debt greater than 74.1% of them.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CMD, try CRL, ENDP, GSK, EDAP, and HZNP.
LITTLE FALLS, N.J., Oct. 1, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP (NYSE:CMD) announced today that Michael Drexel has been hired as Senior Vice President and Chief Technology Officer reporting to George Fotiades, Chief Executive Officer. Michael is based in Plymouth, Minnesota. Mr….
Companies Reporting Before The Bell • Apogee Enterprises (NASDAQ: APOG ) is projected to report quarterly earnings at $0.30 per share on revenue of $314.73 million. • Cantel Medical (NYSE: CMD ) is expected to report … Full story available on Benzinga.com